OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.700
-0.040 (-2.30%)
At close: Mar 28, 2025, 4:00 PM
1.701
+0.001 (0.04%)
After-hours: Mar 28, 2025, 7:57 PM EDT
OPKO Health Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for OPKO Health stock have an average target of 2.75, with a low estimate of 2.25 and a high estimate of 3.00. The average target predicts an increase of 61.76% from the current stock price of 1.70.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OPKO Health stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +76.47% | Mar 19, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +76.47% | Mar 12, 2025 |
Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +32.35% | Mar 12, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +76.47% | Mar 3, 2025 |
Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +32.35% | Feb 28, 2025 |
Financial Forecast
Revenue This Year
694.99M
from 713.14M
Decreased by -2.55%
Revenue Next Year
738.43M
from 694.99M
Increased by 6.25%
EPS This Year
-0.32
from -0.08
EPS Next Year
-0.23
from -0.32
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 797.3M | 818.0M | 901.3M | ||
Avg | 695.0M | 738.4M | 830.7M | ||
Low | 625.2M | 669.9M | 770.9M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 11.8% | 17.7% | 22.1% | ||
Avg | -2.5% | 6.3% | 12.5% | ||
Low | -12.3% | -3.6% | 4.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.19 | -0.16 | -0.11 |
Avg | -0.32 | -0.23 | -0.11 |
Low | -0.59 | -0.43 | -0.12 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.